![Logo for 2cureX](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fe2758-2023-02-25-10-36-55.png&w=256&q=100)
2cureX Investor Relations Material
Latest events
![Logo for 2cureX](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fe2758-2023-02-25-10-36-55.png&w=128&q=100)
Investor Update
2cureX
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from 2cureX
Access all reports
2cureX is a leader in cancer drug sensitivity testing and has developed the IndiTreat® (Individual Treatment) family of tests. Starting from a sample of the patient’s tumor, IndiTreat® creates thousands of 3D replicas (tumoroids) and predicts the tumor response to the different available drugs, providing the physician with valuable information to make the treatment decisions.
The first three IndiTreat® tests are aimed at optimizing treatment decisions in patients with metastatic colorectal cancer (IndiTreat® Start for first line of therapy, IndiTreat® Extend and Explore for third line). Additional tests are under development to cover other stages of colorectal cancer as well as other gastrointestinal cancers.
According to several reports, the total yearly expenditure in cancer-related In Vitro Diagnostic (IVD) tests exceeds 17.5Bn USD worldwide, from which 2.5 Bn USD are tests directly related to therapy decision making, with a CAGR of 12.7%. Despite this, only one third of all cancer treatments are supported by one of these tests. IndiTreat® aims at filling this gap and making Precision Oncology available to all cancer patients.
The company is listed on Nasdaq First North Growth Market in Stockholm (symbol: "2CUREX"). For more information about 2cureX visit www.2cureX.com
Key slides for 2cureX
![In practice ...
I](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2F2curex-investor-update-fb51bb0251adae67%2F9.png&w=3840&q=75)
![Logo for 2cureX](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fe2758-2023-02-25-10-36-55.png&w=128&q=100)
Investor Update
2cureX
![2023 Goals - quarter](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2F2curex-investor-update-fb51bb0251adae67%2F5.png&w=3840&q=75)
![Logo for 2cureX](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fe2758-2023-02-25-10-36-55.png&w=128&q=100)
Investor Update
2cureX
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
2CUREX
Country
🇸🇪 Sweden